Sort
21,281 grants matching “influenza”
Pre-Existing Atopy and Respiratory Viral Infections
$721,121Mitchell H Grayson · Research Inst Nationwide Children'S Hosp · R01 · FY2024 · AI
Development of vaccine approaches to elicit broadly protective influenza-specific immune responses in infants
$721,045Martha A. Alexander-Miller · Wake Forest University Health Sciences · R01 · FY2024 · AI
Small-molecule exploitation of ZBP1-driven nuclear necroptosis for cancer immunotherapy
$721,035Siddharth Balachandran · Research Inst Of Fox Chase Can Ctr · R01 · FY2024 · CA
T5000 Diagnostic System in Ferret Model of Influenza
$720,975Frederick T Koster · Lovelace Biomedical & Environmental Research Institute · U01 · FY2008 · AI
HMGB1-mediated host response to chronic bacterial infection
$720,698Steven D Goodman · Research Inst Nationwide Children'S Hosp · R01 · FY2023 · AI
HMGB1-mediated host response to chronic bacterial infection
$720,698Steven D Goodman · Research Inst Nationwide Children'S Hosp · R01 · FY2022 · AI
Inflammatory Response in Influenza Virus Infection
$720,692Thomas M Moran · Icahn School Of Medicine At Mount Sinai · U01 · FY2010 · AI
Motivational Interviewing Training to Promote COVID-19 and Influenza Vaccination (MI-VAX): What Providers Need and Patients Want
$720,657Kimberly Fisher · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · MD
Meditation and Exercise for Preventing Acute Respiratory Infection (MEPARI-2)
$720,463Bruce P Barrett · University Of Wisconsin-Madison · R01 · FY2014 · AT
Impact of repeated vaccination on the effectiveness of seasonal influenza vaccines
$720,420Xiufeng Henry Wan · University Of Missouri-Columbia · R01 · FY2022 · AI
Mechanism, Function, and Exploitation of Influenza A Virus-Activated Cell Death
$720,326Siddharth Balachandran · Research Inst Of Fox Chase Can Ctr · R01 · FY2024 · AI
Mechanism, Function, and Exploitation of Influenza A Virus-Activated Cell Death
$720,326Siddharth Balachandran · Research Inst Of Fox Chase Can Ctr · R01 · FY2023 · AI
Mucosal Helper-dependent Adenovirus Vaccines Against HIV
$720,202Michael A Barry · Mayo Clinic Rochester · R56 · FY2009 · AI
Project 1: Perturbation of Pre-Existing Immunity to Chronic Viral Infection Through Immunotherapy
$720,185Georg Michael Lauer · Massachusetts General Hospital · U19 · FY2019 · AI
Predictive Biosignatures for Complicated Novel H1N1 Influenza
$720,061Gilles Clermont · University Of Pittsburgh At Pittsburgh · R56 · FY2012 · AI
Effects of aging on primary and secondary vaccine responses in a 15-year longitudinal cohort
$719,974Scott Dexter Boyd · Stanford University · R01 · FY2020 · AI
Programming Durable Immune Responses To Vaccination
$719,857Ali Hassan Ellebedy · Washington University · U01 · FY2019 · AI
Genetic Markers of Long-Term Mumps Vaccine Immunity
$719,830Richard B Kennedy · Mayo Clinic Rochester · R01 · FY2016 · AI
Inborn errors of immunity in patients with life-threatening COVID-19
$719,724Jean-Laurent Casanova · Rockefeller University · R01 · FY2025 · AI
Development of a High-Throughput Microfluidics-Enabled Functional Assay for Rapidly Identifying Neutralizing Antibodies
$719,651Paul De Figueiredo · Texas A&M University · R01 · FY2020 · AI
Restoring age-dependent vaccine unresponsiveness by a novel ASP-1 adjuvant combination
$719,415Sara Lustigman · New York Blood Center · U01 · FY2023 · AI
Restoring age-dependent vaccine unresponsiveness by a novel ASP-1 adjuvant combination
$719,415Sara Lustigman · New York Blood Center · U01 · FY2022 · AI
Restoring age-dependent vaccine unresponsiveness by a novel ASP-1 adjuvant combination
$719,415Sara Lustigman · New York Blood Center · U01 · FY2025 · AI
Restoring age-dependent vaccine unresponsiveness by a novel ASP-1 adjuvant combination
$719,415Sara Lustigman · New York Blood Center · U01 · FY2024 · AI
Engineering protease-resistant alpha-beta peptides for broad-spectrum antivirals
$719,193Anne Moscona · Columbia University Health Sciences · R01 · FY2019 · AI